Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
Public ClinicalTrials.gov record NCT06173531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
Study identification
- NCT ID
- NCT06173531
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- ACADIA Pharmaceuticals Inc.
- Industry
- Enrollment
- 170 participants
Conditions and interventions
Conditions
Interventions
- Carbetocin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years to 30 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 26, 2023
- Primary completion
- Sep 30, 2025
- Completion
- Oct 31, 2025
- Last update posted
- Sep 9, 2025
2023 – 2025
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's of Alabama | Birmingham | Alabama | 35233 | — |
| Phoenix Children's Hospital | Phoenix | Arizona | 85006 | — |
| University of California Irvine | Orange | California | 92697 | — |
| Stanford University School of Medicine | Palo Alto | California | 94304 | — |
| Rady Children's Hospital San Diego | San Diego | California | 92123 | — |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | — |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| SSM Health/Saint Louis University | St Louis | Missouri | 63104 | — |
| Maimonides Medical Center | Brooklyn | New York | 11219 | — |
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | — |
| UPMC-Children's Hospital Pittsburgh | Pittsburgh | Pennsylvania | 15224 | — |
| Vanderbilt Clinical Research Center | Nashville | Tennessee | 37232 | — |
| Cook Children's Health Care System | Fort Worth | Texas | 79104 | — |
| Christus Children's | San Antonio | Texas | 78207 | — |
| University of Utah | Salt Lake City | Utah | 84108 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06173531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06173531 live on ClinicalTrials.gov.